SK56 is a GSDMD-NT pore inhibitor. SK56 inhibits pyroptosis (Pyroptosis) and the release of pyroptosis-related cytokines in macrophages and human peripheral blood leukocytes. SK56 prevents extensive cell death in human alveolar organoids in an organoid-macrophage co-culture model. SK56 prevents death from infectious shock induced by LPS (HY-D1056) or cecal ligation and puncture in mice. SK56 can be used in studies related to sepsis[1].
Molecular Weight:
6532.50
Formula:
C289H479N79O88S2
Target:
Pyroptosis
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted